These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22115795

  • 1. Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells.
    Yoon HE, Kim SA, Choi HS, Ahn MY, Yoon JH, Ahn SG.
    Cancer Lett; 2012 Mar; 316(1):97-104. PubMed ID: 22115795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
    Wang Y, Wu L, Yao Y, Lu G, Xu L, Zhou J.
    Cancer Lett; 2018 Nov 01; 436():1-9. PubMed ID: 30118839
    [Abstract] [Full Text] [Related]

  • 7. Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition.
    Lange L, Hemmerich P, Spänkuch B.
    Oncotarget; 2015 Sep 22; 6(28):25801-14. PubMed ID: 26317649
    [Abstract] [Full Text] [Related]

  • 8. In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
    Van den Bossche J, Deben C, De Pauw I, Lambrechts H, Hermans C, Deschoolmeester V, Jacobs J, Specenier P, Pauwels P, Vermorken JB, Peeters M, Lardon F, Wouters A.
    Mol Oncol; 2019 May 22; 13(5):1196-1213. PubMed ID: 30859681
    [Abstract] [Full Text] [Related]

  • 9. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
    Ferrarotto R, Goonatilake R, Yoo SY, Tong P, Giri U, Peng S, Minna J, Girard L, Wang Y, Wang L, Li L, Diao L, Peng DH, Gibbons DL, Glisson BS, Heymach JV, Wang J, Byers LA, Johnson FM.
    Clin Cancer Res; 2016 Apr 01; 22(7):1674-1686. PubMed ID: 26597303
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
    Yunoki T, Tabuchi Y, Hayashi A, Kondo T.
    Invest Ophthalmol Vis Sci; 2013 Dec 23; 54(13):8353-63. PubMed ID: 24366665
    [Abstract] [Full Text] [Related]

  • 13. Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).
    Liu-Sullivan N, Zhang J, Bakleh A, Marchica J, Li J, Siolas D, Laquerre S, Degenhardt YY, Wooster R, Chang K, Hannon GF, Powers S.
    Oncotarget; 2011 Dec 23; 2(12):1254-64. PubMed ID: 22248814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
    Ryo A, Hirai A, Nishi M, Liou YC, Perrem K, Lin SC, Hirano H, Lee SW, Aoki I.
    J Biol Chem; 2007 Dec 14; 282(50):36671-81. PubMed ID: 17938171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.